Capital Wealth Alliance’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Capital Wealth Alliance’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$236K	Buy	+1,490	New	+$201K	0.11%	94
2022 Q4	–	Sell	-4,653	Closed	-$369K	–	126
2022 Q3	$369K	Buy	+4,653	New	+$392K	0.31%	70
2020 Q1	–	Sell	-32	Closed	-$3K	–	352
2019 Q4	$3K	Buy	+32	New	+$2.77K	﹤0.01%	291

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

OPCM

Osborne Partners Capital Management San Francisco, California $1.8B AUM 22.23% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

Capital Wealth Alliance's XBI Position: Q2 2026 in Review

Capital Wealth Alliance opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 1,490 shares worth $236K. The stake represents 0.11% of the portfolio and ranks #94 among its holdings. This is a return to the name: Capital Wealth Alliance previously reported a position in XBI as recently as Q3 2022.

Capital Wealth Alliance first reported a position in XBI in Q4 2019 and has held it in 3 quarters since. The position peaked at $369K in Q3 2022. 447 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Capital Wealth Alliance held 1,490 shares of State Street SPDR S&P Biotech ETF worth $236K as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Capital Wealth Alliance position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.11% of Capital Wealth Alliance's portfolio in Q2 2026, its #94 holding.
Capital Wealth Alliance first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 3 quarters since.
Capital Wealth Alliance's State Street SPDR S&P Biotech ETF position peaked at $369K in Q3 2022.
447 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Capital Wealth Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.